Literature DB >> 7852524

Expression of human gonadotropin-releasing hormone receptor gene in the placenta and its functional relationship to human chorionic gonadotropin secretion.

L S Lin1, V J Roberts, S S Yen.   

Abstract

Placental GnRH is one of the potential paracrine regulators of hCG secretion from the trophoblasts during pregnancy. Maternal serum hCG levels exhibit an exponential rise during the first 6 weeks of pregnancy, peak at 9-10 weeks, decline to a nadir at 20 weeks, and remain at low levels during the rest of pregnancy. However, the placental content of GnRH does not parallel the time course of hCG secretion, and GnRH messenger ribonucleic acid (mRNA) levels in the placenta remain unchanged during pregnancy. These data do not conform with a simple paracrine mechanism of GnRH as a regulator of hCG secretion. We, therefore, examined the potential variation in GnRH receptor gene expression in the placenta, which may account for the GnRH-mediated dynamic pattern of hCG secretion during gestation. First, we established a functional relationship of GnRH and hCG secretion. Using a placental explant culture system, a dose-response effect of hCG secretion was observed in the placental explant at 9 weeks when treated with GnRH ranging from 10(-9)-10(-7) mol/L. The effect of GnRH was completely blocked by a GnRH antagonist (Nal-Glu). The relative responsiveness of hCG secretion to GnRH stimulation at 10(-7) mol/L was further evaluated in placental explants at 6, 9, and 40 weeks gestation. Whereas the 9-week placenta showed a maximal response (> 300%) relative to the 6-week placenta, there was no response in term placenta. Again, the effects of GnRH on hCG secretion were blocked by Nal-Glu, supporting a receptor-mediated event. Localization of mRNA encoding human GnRH receptor in human placenta at 6, 9, 12, 20, and 40 weeks gestation was established by in situ hybridization. The mRNA signals were present in both cytotrophoblast and syncytiotrophoblast cell layers. Signal intensities varied with gestational ages and were abundant at 6 weeks, peaked at 9 weeks, declined at 12 and 20 weeks, and were undetectable at term. The present study demonstrates, for the first time, that GnRH receptor mRNA is expressed in both cytotrophoblasts and syncytiotrophoblasts and exhibits changes paralleling the time course of hCG secretion during pregnancy. These data provide a mechanistic understanding that the paracrine/autocrine regulation of hCG secretion by placental GnRH is mediated through an increase followed by a decline in GnRH receptor gene expression from the first trimester to term placenta.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7852524     DOI: 10.1210/jcem.80.2.7852524

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

1.  Gonadotropin-releasing hormone messenger ribonucleic acid and protein expression in Vero cells.

Authors:  H Y Huang; F Raga; J S Kruessel; Y Wen; Y K Soong; M L Polan
Journal:  J Assist Reprod Genet       Date:  2001-05       Impact factor: 3.412

2.  Promotion of human trophoblasts invasion by gonadotropin-releasing hormone (GnRH) I and GnRH II via distinct signaling pathways.

Authors:  Jing Liu; Colin D Maccalman; Yan-ling Wang; Peter C K Leung
Journal:  Mol Endocrinol       Date:  2009-04-16

3.  Administration effects of single-dose GnRH agonist for luteal support in females undertaking IVF/ICSI cycles: A meta-analysis of randomized controlled trials.

Authors:  Mengling Song; Chunlian Liu; Rong Hu; Feimiao Wang; Zhenghao Huo
Journal:  Exp Ther Med       Date:  2019-11-27       Impact factor: 2.447

4.  Biological action of keratinocyte growth factor in BeWo cells, a human choriocarcinoma cell line.

Authors:  H Matsui; M Taga; K Kurogi; M Hiraga; K Suyama; C Ohkouchi; H Minaguchi
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

Review 5.  Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis.

Authors:  João Batista A Oliveira; Ricardo Baruffi; Cláudia G Petersen; Ana L Mauri; Mario Cavagna; José G Franco
Journal:  Reprod Biol Endocrinol       Date:  2010-09-08       Impact factor: 5.211

6.  Effect of in vivo GnRH agonist and GnRH antagonist on hCG and insulin-stimulated progesterone production by human granulosa-lutein cells in vitro.

Authors:  Mohamed F M Mitwally; Robert F Casper
Journal:  J Assist Reprod Genet       Date:  2002-08       Impact factor: 3.412

7.  G protein-coupled receptor expression in the adult and fetal adrenal glands.

Authors:  Yewei Xing; Yasuhiro Nakamura; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2008-11-05       Impact factor: 4.102

8.  Nucleotide sequence analyses predict that human pituitary and human placental gonadotropin-releasing hormone receptors have identical primary structures.

Authors:  T A Boyle; D I Belt-Davis; T M Duello
Journal:  Endocrine       Date:  1998-12       Impact factor: 3.925

9.  GnRH I and II up-regulate MMP-26 expression through the JNK pathway in human cytotrophoblasts.

Authors:  Jing Liu; Bin Cao; Yu-xia Li; Xiao-qiu Wu; Yan-ling Wang
Journal:  Reprod Biol Endocrinol       Date:  2010-01-15       Impact factor: 5.211

10.  GnRH regulates trophoblast invasion via RUNX2-mediated MMP2/9 expression.

Authors:  Bo Peng; Hua Zhu; Christian Klausen; Liyang Ma; Yan-Ling Wang; Peter C K Leung
Journal:  Mol Hum Reprod       Date:  2015-12-11       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.